Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.45 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.37 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.36 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1903390 | 1.00 | NPC1 (0.52) | NPC1L3MBTL1ZDHHC20TSHRTP53 | |
| SCHEMBL1395640 | 1.00 | NPC1 (0.52) | NPC1L3MBTL1ZDHHC20TSHRTP53 | |
| SCHEMBL1022195 | 0.89 | NPC1 (0.54) | NPC1L3MBTL1ZDHHC20TSHRTP53 | |
| SCHEMBL1395649 | 0.89 | NPC1 (0.54) | NPC1L3MBTL1ZDHHC20TSHRTP53 | |
| SCHEMBL1630772 | 0.89 | NPC1 (0.54) | NPC1L3MBTL1ZDHHC20TSHRTP53 | |
| SCHEMBL19917777 | 0.87 | ZDHHC20 (0.50) | NPC1L3MBTL1ZDHHC20TSHRTP53 | |
| SCHEMBL19854404 | 0.87 | ZDHHC20 (0.50) | NPC1L3MBTL1ZDHHC20TSHRTP53 | |
| SCHEMBL31265916 | 0.83 | ZDHHC20 (0.41) | NPC1L3MBTL1ZDHHC20TSHRTP53 | |
| SCHEMBL1832210 | 0.81 | ZDHHC20 (0.53) | ZDHHC20TSHRTP53EGLN1EGLN3 | |
| SCHEMBL1832212 | 0.81 | ZDHHC20 (0.53) | ZDHHC20TSHRTP53EGLN1EGLN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119591659-A | Tripterine acrylamide derivative and preparation method and application thereof | 中国药科大学 | 2025-03-11 | — | — | CN | disclosed |
| WO-2024162401-A1 | DUST-PROOFING MATERIAL, PROTECTIVE CLOTHING AND METHOD FOR PRODUCING DUST-PROOFING MATERIAL | エム・エーライフマテリアルズ株式会社 | 2024-08-08 | — | — | WO | disclosed |
| EP-3512602-B1 | INHIBITORS OF HEAT SHOCK FACTORS (HSF) AND USES THEREOF | HSF PHARMACEUTICALS (CH) | 2024-03-27 | — | — | EP | disclosed |
| US-11912831-B2 | Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers | ISP INVESTMENTS LLC (US) | 2024-02-27 | — | — | US | disclosed |
| US-11515810-B2 | Energy conversion film and energy conversion element using same | YUPO CORPORATION (JP) | 2022-11-29 | — | — | US | disclosed |
| WO-2022210605-A1 | RECORDING PAPER | 株式会社ユポ・コーポレーション | 2022-10-06 | — | — | WO | disclosed |
| EP-3550620-B1 | PIEZOELECTRIC ELEMENT AND MUSICAL INSTRUMENT | YUPO CORP (JP) | 2022-05-04 | — | — | EP | disclosed |
| CN-110214358-B | Energy conversion film and energy conversion element using same | 优泊公司 | 2022-03-22 | — | — | CN | disclosed |
| US-7482379-B2 | Propenoyl hydrazides | GEORGIA TECH RESEARCH CORPORATION (US) | 2009-01-27 | — | — | US | disclosed |
| US-20050256058-A1 | Propenoyl hydrazides | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912831-B2 | Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers | MMAB, PCNA, HMBS | NPC1 4879/4885L3MBTL1 1589/4885ZDHHC20 4590/4885 |
| US-20050256058-A1 | Propenoyl hydrazides | DNPEP, HPN, PREP | NPC1 2408/4885L3MBTL1 2501/4885ZDHHC20 819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.